IBEX Technologies

IBEX Technologies is a Montreal-based company that, through its wholly-owned subsidiary IBEX Pharmaceuticals Inc., produces and sells reagents for biomedical use. The company specializes in the production and sale of proprietary enzymes critical for clinical diagnostics, including glycosaminoglycan (GAG) enzymes widely used in research fields. Its product portfolio includes high-purity enzymes for in vitro diagnostics and research, as well as ELISA kits for osteoarthritis studies. IBEX also provides custom manufacturing services to key players in the in vitro diagnostics market, including custom fermentation and the filling and lyophilization of single-use diagnostic components. Leveraging its advanced manufacturing capabilities and extensive enzymology expertise, IBEX supports the development of biomedical diagnostics, advancing clinical research and healthcare outcomes.